Yes, it's new and there will be setbacks. There will be new methods and pathways moving forward, but I don't think that will stop the development of this technology, just like how the Cytokine Release Syndrome didn't stop the development of CAR-T.
My argument stands, if CHM's product is successful down the line when that time comes, there would be better therapies with better efficacy and technology in the market so tell me what would be the point of CHM's products?
Charting Only, page-100
-
- There are more pages in this discussion • 353 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CHM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
1.4¢ |
Change
0.000(0.00%) |
Mkt cap ! $12.67M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
| CHM (ASX) Chart |
Day chart unavailable